Global Hepatitis Diagnostic Test Databank Market Report

Global Hepatitis Diagnostic Test Databank Market Report

The Hepatitis Diagnostic Test market was valued at $4,621.3 Million in 2022, and is projected to reach $7,408.8 Million by 2031 growing at a CAGR of 5.43% from 2023 to 2031. Blood tests segment is expected to be the highest contributor to this market, with $2,457.2 Million in 2022, and is anticipated to reach $3,721.6 Million by 2031, registering a CAGR of 4.76%. Liver Biopsy segment is anticipated to reach $1,122.8 Million by 2031 with the highest CAGR of 6.87%. Blood tests and Imaging Tests segments collectively expected to account for about 86.6% share of the Hepatitis Diagnostic Test market in 2022, with the former constituting around 53.2% share. Liver Biopsy and Imaging Tests segments are expected to witness significant growth rates at a CAGR of 6.87% and 5.84% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 46.8% in the overall Hepatitis Diagnostic Test market in 2022, and is anticipated to reach 49.8% by 2031.